Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

Blood Cancer Journal, Published online: 21 September 2023; doi:10.1038/s41408-023-00915-6Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

Source: Blood Cancer Journal - September 21, 2023 Category: Hematology Authors: Danielle Hammond Sanam Loghavi Sa A. Wang Marina Y. Konopleva Tapan M. Kadia Naval G. Daver Maro Ohanian Ghayas C. Issa Yesid Alvarado Nicholas J. Short Koji Sasaki Naveen Pemmaraju Guillermo Montalban-Bravo Curtis A. Lachowiez Abhishek Maiti Guillermo Ga Source Type: research